Skip to main content
Equibles
CRVS $10.46 -0.76%
CRVS logo
CRVS · Corvus Pharmaceuticals, Inc.
Track CRVS — free

Use CRVS with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CRVS.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$10.46 -0.08 (-0.76%) Q2 2026 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$886.63M
Shares
84.12M
Volume · Oct 28 390.55K Avg daily vol (3M) 996.23K
All webcasts

Earnings call · FY2019 Q4

Corvus Pharmaceuticals, Inc. (CRVS) Q4 2019 Earnings Call

Concluded Mar 5, 2020
Mar 5, 2020 0 turns
Period
FY2019 Q4
Runtime
—
Sources
2 artifacts
Diluted EPS $0.92
Net income -$11.05M
Open full screen 8-K 10-K

Executive readout · one minute

Webcast research workspace

Read the call alongside every captured source. 8-K earnings release, 10-K stay in one workspace.

Research coverage

2 live sources

Open each available source without leaving this research workspace.

Research materials

Open the source you need; every reader stays inside this workspace.

8-K earnings release Filed Mar 5, 2020 10-K report Filed Mar 9, 2020
Full-screen source Call document

CRVS alerts

Corvus Pharmaceuticals, Inc.

Create a free account or sign in to receive transcript alerts at your email address.

Continue to sign in
Read transcripts like this one from Claude, ChatGPT or your own code with the earnings call transcript API →